-
Why metal prices are soaring to record highs
-
Stocks tepid in thin pre-Christmas trade
-
UN experts slam US blockade on Venezuela
-
Bethlehem celebrates first festive Christmas since Gaza war
-
Set-piece weakness costing Liverpool dear, says Slot
-
Two police killed in explosion in Moscow
-
EU 'strongly condemns' US sanctions against five Europeans
-
Arsenal's Kepa Arrizabalaga eager for more League Cup heroics against Che;sea
-
Thailand-Cambodia border talks proceed after venue row
-
Kosovo, Serbia 'need to normalise' relations: Kosovo PM to AFP
-
Newcastle boss Howe takes no comfort from recent Man Utd record
-
Frank warns squad to be 'grown-up' as Spurs players get Christmas Day off
-
Rome pushes Meta to allow other AIs on WhatsApp
-
Black box recovered from Libyan general's crashed plane
-
Festive lights, security tight for Christmas in Damascus
-
Zelensky reveals US-Ukraine plan to end Russian war, key questions remain
-
El Salvador defends mega-prison key to Trump deportations
-
Stranger Things set for final bow: five things to know
-
Grief, trauma weigh on survivors of catastrophic Hong Kong fire
-
Asian markets mixed after US growth data fuels Wall St record
-
Stokes says England player welfare his main priority
-
Australia's Lyon determined to bounce back after surgery
-
Stokes says England players' welfare his main priority
-
North Korean POWs in Ukraine seeking 'new life' in South
-
Japanese golf star 'Jumbo' Ozaki dies aged 78
-
Johnson, Castle shine as Spurs rout Thunder
-
Thai border clashes hit tourism at Cambodia's Angkor temples
-
From predator to plate: Japan bear crisis sparks culinary craze
-
Asian markets mostly up after US growth fuels Wall St record
-
'Happy milestone': Pakistan's historic brewery cheers export licence
-
Chevron: the only foreign oil company left in Venezuela
-
US denies visas to EU ex-commissioner, four others over tech rules
-
Dynamite Blockchain Delivers Record Q3 2025
-
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
-
SMX's Integrated Value Proposition: One System, Many Markets, Compounding Leverage
-
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
-
Goldgroup Secures Ownership of the San Francisco Gold Mine Acquiring 100% of Molimentales del Noroeste, S.A. De C.V.
-
Alta Copper Announces Filing and Mailing of Meeting Materials for the Special Meeting of Shareholders and Optionholders to be Held on January 26, 2026
-
Pantheon Resources PLC Announces TR-1: Notification of Major Holdings
-
Bridgeline Expands Footprint with Closeout Retailer Choosing HawkSearch for Its On-Site Search Experience and Personalization
-
Koepka leaves LIV Golf: official
-
US slams China policies on chips but will delay tariffs to 2027
-
Arsenal reach League Cup semis with shoot-out win over Palace
-
Contenders Senegal, Nigeria start Cup of Nations campaigns with wins
-
Tunisia ease past Uganda to win Cup of Nations opener
-
S&P 500 surges to record after strong US economic report
-
UK police say no action against Bob Vylan duo over Israel army chant
-
Libya's top military chief killed in plane crash in Turkey
-
Venezuela passes law to jail backers of US oil blockade
-
French parliament passes emergency budget extension
Tainted fentanyl blamed for 87 hospital deaths in Argentina
At least 87 people have died in Argentina after being administered bacteria-infected fentanyl in hospitals, a judge investigating the deaths said Wednesday.
Since May, a court has been trying to determine how many deaths are linked to batches of the drug contaminated with the bacteria Klebsiella pneumoniae and Ralstonia pickettii.
The suspected toll has soared since then, with family members holding protests outside hospitals demanding justice.
The probe arose from a complaint filed by Argentina's drug regulatory agency, Anmat, which had received a report from a hospital that discovered the tainted drug in its supply, an Anmat employee told AFP on condition of anonymity.
The deaths have occurred in hospitals in the city and province of Buenos Aires, and in three other provinces, the judge leading the investigation, Ernesto Kreplak, told The Nation daily newspaper in an article published Wednesday.
At least 24 people have been questioned and had their assets frozen by the court.
They include Ariel Furfaro Garcia, owner of HLB Pharma and Ramallo Laboratories, which allegedly produced and sold the contaminated drug, The Nation reported.
He denied the claims and blamed a former colleague for having planted the story in the media.
"This was fabricated by the media. All the clinical histories show that the patients had other, more dangerous bacteria, people with serious problems," Furfaro Garcia told the daily newspaper Clarin.
According to The Nation, at least five contaminated batches were distributed to eight hospitals and health centers in the country, although the investigation is looking at clinical histories from 200 hospitals.
Two weeks ago, relatives of victims demonstrated outside the Italian Hospital in La Plata, 60 kilometers (37 miles) south of Buenos Aires, where the first deaths were reported, demanding "justice for the fentanyl victims."
"The fentanyl caused his death in a matter of days," Alejandro Ayala, whose brother Leonel died at the age of 32, told AFP.
Experts have warned that the death toll could rise as new medical records are reviewed and cases are confirmed in hospitals that to date had not reported any fentanyl-linked deaths.
Argentina's Congress on Wednesday submitted 26 questions related to the case to the Executive branch of the government, but no deadline has been set for their response.
X.Karnes--AMWN